Nabota 100ui
- Bulk Discount From 5 PCS
- Get 5% extra discount by using WISE or Bank Transfer
Nabota 100U — Vacuum-dried Clostridium botulinum toxin type A from Daewoong. MFDS (KFDA) approved. Its active (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). The Korean Nabota brand itself is not FDA-approved. Note: vacuum-drying produces thin film at vial bottom — vial may appear empty. For licensed healthcare professionals only.
$39.80
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 3% | $38.61 |
| 10-19 | 5% | $37.81 |
| 20-Unlimited | 8% | $36.62 |
Nabota 100U — Vacuum-Dried Botulinum Toxin Type A
What it is
Nabota 100U is a vacuum-dried Clostridium botulinum toxin type A produced by Daewoong in South Korea. Each vial contains 100 units. Nabota is MFDS (KFDA) approved in Korea. Its active ingredient (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). The Korean Nabota brand itself is not FDA-approved. The vacuum drying process preserves molecular integrity during production. Requires reconstitution with sterile preservative-free 0.9% saline before use.
What makes it distinctive
Nabota’s defining feature is vacuum-drying technology — preserved molecular integrity with minimal excipients. MFDS (KFDA) approved in Korea. The 900 kDa molecular complex is biosimilar to Allergan Botox, allowing direct 1:1 dose translation. Its active ingredient (prabotulinumtoxinA) is FDA-approved in the US as Jeuveau (Evolus Inc., 2019).
How vacuum drying works
Nabota uses vacuum drying rather than conventional freeze-drying — this prevents ice nuclei formation during the drying step, which is a source of inactive toxin formation in freeze-dried products. The result: higher proportion of active 900 kDa neurotoxin per vial and longer shelf stability. The trade-off is unfamiliar visual appearance — vacuum-dried Nabota leaves a thin film at the vial bottom rather than a visible powder cake.
Approved & off-label indications
Technical specifications
Detail for clinical, regulatory, and shipping reference.
| Active Ingredient | Clostridium botulinum toxin type A |
| Molecular Complex | 900 kDa (biosimilar to Allergan Botox) |
| Units per vial | 100 units |
| Form | Vacuum-dried powder (thin film at vial bottom) |
| Excipients | HSA + NaCl (preservative-free) |
| Manufacturer | Daewoong |
| Origin | South Korea |
| Approvals | MFDS (KFDA) approved · Manufactured in Korea |
| Onset / Duration | 2–4 days onset · peak day 7 · 3–5 months duration |
| Reconstitution | Sterile preservative-free 0.9% saline |
| Storage | 2–8 °C, protect from light, do not freeze |
| Reconstituted shelf life | 24 hours at 2–8 °C |
| Shelf life (unopened) | 36 months from manufacture |
| Intended use | Licensed medical professionals only |
Frequently Asked Questions
Nabota uses Daewoong’s vacuum-drying production process — the botulinum toxin powder forms an ultra-thin, almost invisible film at the vial bottom rather than a visible powder cake. The vial really does look empty — this is normal for vacuum-dried botulinum products, not a packaging error or fake product. Hold the vial up to bright light at an angle to see the faint translucent film. When you add saline for reconstitution, the film dissolves and the product behaves identically to any other reconstituted botulinum toxin.
Its active (prabotulinumtoxinA) is FDA-approved in the US under the separate brand Jeuveau (2019). The Korean Nabota brand itself is not FDA-approved. In the US it is marketed as Jeuveau by Evolus Inc. Jeuveau is the only botulinum toxin in the US market approved exclusively for aesthetic use.
Conventional freeze-drying creates ice crystals that can damage botulinum toxin protein, generating inactive complexing proteins. Vacuum-drying avoids this ice-damage pathway, preserving active 900 kDa neurotoxin content and reducing inactive protein load. The result: a thin film at the vial bottom rather than a visible powder cake.
Both products use the 900 kDa molecular complex, making units directly translatable — clinicians can substitute Nabota 1:1 for Allergan Botox in dosing protocols. Vacuum-drying differs from Allergan’s freeze-drying. Clinical efficacy is comparable per head-to-head global trials covering 2,000+ patients.
Duration is typically 3–5 months in standard cosmetic indications. Onset is rapid at 2–4 days post-injection with peak effect at approximately day 7 — faster onset than typical freeze-dried Korean botulinums. Mobile facial zones may resorb faster than static zones.
Nabota holds approximately 32% market share among Korean botulinum products in Korea — second only to Hugel’s Botulax. Korean practitioners value Nabota for its fast onset and natural-looking results that preserve facial expression. Domestic Korean market leadership makes Nabota a premium tier Korean botulinum.
Look for: (1) Daewoong branding on outer carton; (2) batch number matching between box and vial; (3) intact tamper-evident vial seal; (5) the empty-looking vial is normal — do not reject Nabota based on visual emptiness alone; (6) for US-market Jeuveau version, look for Evolus Inc. distributor reference.
Related Products
Other botulinum toxin products from MJS Medicals — different manufacturers, formulations, and price points.
Nabota 200U
Same Daewoong vacuum-dried formulation at 200-unit pack. Jeuveau equivalent in the US.
Botulax 100U
Korea’s #1 botulinum brand — Hugel, US FDA approved as Letybo.
Allergan Botox 50U
Global gold-standard botulinum — Korean-imported English-labeled version.
View product →
Browse all botulinum toxin products at MJS Medicals.
Safety
This product-specific: Nabota 100U uses vacuum-drying technology — the empty-looking vial is normal and does not indicate a fake product. Nabota 100U carries the same class-wide botulinum toxin warnings as all Type A products including potential distant toxin spread, neuromuscular junction disorder contraindications, and pregnancy/lactation contraindication. Always aspirate before injection; maintain emergency airway management equipment.
Botulinum toxin Type A is a prescription medical product for licensed healthcare professionals only. Contraindicated in neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton, ALS); known hypersensitivity to botulinum toxin or excipients; pregnancy / breastfeeding; active local infection; concurrent aminoglycoside / anticholinesterase / curare-like drugs. Class-wide warning: rare distant toxin spread possible (symptoms hours-to-weeks post-injection). Maintain emergency airway management equipment and epinephrine.
Related Products
Dysport 500u
Dysport 500U Korean-imported — genuine AbobotulinumtoxinA manufactured by Ipsen Pharma (France/UK). English-labeled, Korean wholesale import. ⚠ Units NOT interchangeable with Botox (2.5:1 ratio). abobotulinumtoxinA — FDA-approved (2009, Ipsen/Galderma). CE marked. For licensed healthcare professionals only.
Hitox 100u
Wondertox 200U
Innotox 50ui
Kaimax 200u
Hitox 200u
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More


3 reviews for Nabota 100ui
Clear filters